Concepedia
Statistics
Publications
5
Citations
180
H-Index
Active since
2016
Affiliations
Seoul National University Hospital(Current)
Regeneron (United States)
Columbia University Irving Medical Center
Seoul National University
Ha-Ram Park is an author at Seoul National University Hospital specializing in oncology, medicine, and cancer immunotherapy.
Publications per year
2016–2023
Inhibition of MEK with trametinib enhances the efficacy of anti-PD-L1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinoma
Seong-Ho Kang, Bhumsuk Keam, Yong‐Oon Ahn et al. · OncoImmunology · 2018 · 72 citations · Full text
Medicine, Oncology, Pharmacology +17
Angiopoietin-2–Dependent Spatial Vascular Destabilization Promotes T-cell Exclusion and Limits Immunotherapy in Melanoma
Ha-Ram Park, Anahita Shiva, Portia Cummings et al. · Cancer Research · 2023 · 47 citations · Full text
Medicine, Immunology, Oncology +17
Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors in Patients With De Novo EGFRT790M-Mutant NSCLC
Ha-Ram Park, Tae Min Kim, Yusoo Lee et al. · Journal of Thoracic Oncology · 2021 · 27 citations · Full text
Medicine, Oncology, Pharmacology +14
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
Casey R. Ager, Matthew J. Reilley, Courtney Nicholas et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text
Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitment
Eunhyeong Lee, Sophie O'Keefe, Alessandra Leong et al. · Journal of Clinical Investigation · 2023 · 17 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 5